ESC 365 - Is it safe to defer revascularisation in asymptomatic patients with chronic coronary syndrome with FFR-CT positive stenoses?

ESC2025 Premium Access

Is it safe to defer revascularisation in asymptomatic patients with chronic coronary syndrome with FFR-CT positive stenoses?

Session: Young Investigator Award Session in Atherothrombosis, Coronary, Aortic, and Peripheral Artery Disease

Topic: Noninvasive Diagnostic Methods

Speaker: Doctor R. Chotalia (Lincoln, GB)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Ravi Chotalia

Lincoln County Hospital, Lincoln (United Kingdom of Great Britain & Northern Ireland)

0 follower

3 more presentations in this session

Trends and cross-country inequalities in the global burden of early-onset atherosclerosis - a population-based study

Speaker: Doctor Y. Du (Beijing, CN)

Endotypes of angina with non-obstructive coronary arteries

Speaker: Doctor O. Velollari (Mainz, DE)

Long forms of cardiac troponin T to differentiate troponin elevations in atrial fibrillation and acute myocardial infarction

Speaker: Doctor K. Teppo (Turku, FI)

Access the full session

Young Investigator Award Session in Atherothrombosis, Coronary, Aortic, and Peripheral Artery Disease

Speakers: Doctor R. Chotalia, Doctor Y. Du, Doctor O. Velollari, Doctor K. Teppo

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources